Assignee
THETIS PHARMACEUTICALS LLC
US·16 granted patents·5 pending applications·48 citations·filing 2013–2024
Top patents by PatentIndex Score
21 records- 0196US8765811B2Tri-salt form of metforminTHETIS PHARMACEUTICALS LLC·Filed 2013·Granted Jul 1, 2014·11 cites·4 claims
- 0295US8933124B2Tri-salt form of metforminTHETIS PHARMACEUTICALS LLC·Filed 2014·Granted Jan 13, 2015·8 cites·4 claims
- 0391US10420843B2Compositions and methods relating to salts of specialized pro-resolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2017·Granted Sep 24, 2019·3 cites·22 claims
- 0491US10130719B2Compositions and methods relating to salts of specialized pro-resolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2017·Granted Nov 20, 2018·3 cites·30 claims
- 0589US9242008B2Mineral amino-acid complexes of fatty acidsTHETIS PHARMACEUTICALS LLC·Filed 2014·Granted Jan 26, 2016·8 cites·27 claims
- 0686US9505709B2Compositions and methods relating to ionic salts of peptidesTHETIS PHARMACEUTICALS LLC·Filed 2015·Granted Nov 29, 2016·6 cites·46 claims
- 0780US9999626B2Mineral amino-acid complexes of active agentsTHETIS PHARMACEUTICALS LLC·Filed 2015·Granted Jun 19, 2018·4 cites·57 claims
- 0878US9382187B2Tri-salt form of metforminTHETIS PHARMACEUTICALS LLC·Filed 2013·Granted Jul 5, 2016·1 cites·40 claims
- 0978US8901107B2Lipid-lowering antidiabetic agentTHETIS PHARMACEUTICALS LLC·Filed 2013·Granted Dec 2, 2014·2 cites·5 claims
- 1077US11925688B2Compositions and methods relating to salts of specialized pro-resolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2021·Granted Mar 12, 2024·0 cites·14 claims
- 1175US11135298B2Compositions and methods relating to salts of specialized pro-resolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2019·Granted Oct 5, 2021·0 cites·33 claims
- 1274US9216951B2Lipid-lowering antidiabetic agentTHETIS PHARMACEUTICALS LLC·Filed 2014·Granted Dec 22, 2015·1 cites·10 claims
- 1374US9012507B2Lipid-lowering antidiabetic agentTHETIS PHARMACEUTICALS LLC·Filed 2013·Granted Apr 21, 2015·1 cites·3 claims
- 1469US2024156909A1Compositions and methods for cancer therapyTHETIS PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1566US12564644B2Cyclodextrin complexes of specialized proresolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2023·Granted Mar 3, 2026·0 cites·18 claims
- 1666US11191840B2Compositions and methods relating to salts of specialized pro-resolving mediatorsTHETIS PHARMACEUTICALS LLC·Filed 2018·Granted Dec 7, 2021·0 cites·19 claims
- 1765US11986512B2Compositions and methods for cancer therapyTHETIS PHARMACEUTICALS LLC·Filed 2022·Granted May 21, 2024·0 cites·44 claims
- 1861US2024180859A1Compositions and methods for immune-mediated inflammatory diseasesTHETIS PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1951US2014148464A1Salt forms of fatty acids for the treatment of dry eyeTHETIS PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 2045US2017096449A1Compositions and Methods Relating to Ionic Salts of PeptidesTHETIS PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 2139US2017119841A1Amino acid salts of unsaturated fatty acidsTHETIS PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THETIS PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →